Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment

The use of cancer-derived exosomes has been studied in several cancer types, but the cancer-targeting efficacy of glioma-derived exosomes has not been investigated in depth for malignant glioblastoma (GBM) cells. In this study, exosomes were derived from U87MG human glioblastoma cells, and selumetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyeji, Bae, Kanghye, Baek, Ah-Rum, Kwon, Eun-Bin, Kim, Yeoun-Hee, Nam, Sung-Wook, Lee, Gang Ho, Chang, Yongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145309/
https://www.ncbi.nlm.nih.gov/pubmed/35631588
http://dx.doi.org/10.3390/pharmaceutics14051002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145309/
https://www.ncbi.nlm.nih.gov/pubmed/35631588
http://dx.doi.org/10.3390/pharmaceutics14051002

Ejemplares similares